Delivery Order SPE2DB20D3101-SPE2DB23FRRY7
- Not listed
- This federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, was issued by the Defense Logistics Agency (DLA) for the delivery of Prilosec DR 10 mg suspension medication in 30-count packages. The $5,973.37 firm-fixed-price delivery order does not have a set-aside designation, indicating open competition. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for providing a...
- This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The award, worth $1,050.64, is for the delivery of Prilosec DR 2.5 mg suspension medication. The contract is a Firm Fixed Price Delivery Order that will run through March 28, 2025. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and...
- The Defense Logistics Agency (DLA) awarded a $4,267.23 firm-fixed-price delivery order to AmerisourceBergen Drug Corp's Corporate Office Division for the supply of 4,565,482,490 units of Prilosec DR 2.5 mg suspension 30-count. This delivery order falls under an existing Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at up to $999,999,999 through December 2025, for a comprehensive range of medical commodities to support military treatment programs and facilities...
- This federal contract award to Amerisourcebergen Drug Corp is a Delivery Order (SPE2DB20D3101|SPE2DB24FRBE2) from the Defense Logistics Agency (DLA) for the supply of Prilosec DR 2.5 mg Suspension, valued at $12,325.17. The contract has a ceiling value of $12,325.17 and an ultimate completion date of February 9, 2024. This award is not designated as a set-aside contract. Amerisourcebergen Drug Corp is a major pharmaceutical distributor and healthcare solutions provider that plays a critical role...
- The Defense Logistics Agency awarded a $1,498.98 firm fixed-price delivery order to AmerisourceBergen Drug Corp for Prilosec DR 10 mg suspension (30-count) on January 23, 2026, with completion targeted for January 26, 2026. This non-set-aside award was issued under a competitive process and represents a task order against AmerisourceBergen's larger indefinite delivery contract with DLA Troop Support Medical. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, serves as a critical...
- This federal contract award, with ID SPE2DB20D3101|SPE2DB23FRYE3, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of the parent company Cencora, Inc. The $25,395.84 firm-fixed-price delivery order is for the supply of Prilosec DR 10 mg suspension in 30-count packages. The contract has an ultimate completion date of September 20, 2023. The award was not designated with a set-aside requirement, indicating open competition. Amerisourcebergen Drug...
- The Defense Logistics Agency awarded a delivery order valued at $10,156.92 to AmerisourceBergen Drug Corp for the supply of Prilosec DR 10 mg suspension (30-count). This firm fixed-price delivery order, issued on July 22, 2025, with an ultimate completion date of July 23, 2025, represents a non-set-aside award executed through open competition. The place of performance is AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued as a child...
- The Defense Logistics Agency awarded a delivery order valued at $2,602.00 to AmerisourceBergen Drug Corp for the supply of Prilosec DR 10 mg Suspension (30-count). This competitive award, issued on January 21, 2026, with an ultimate completion date of January 22, 2026, represents a firm fixed-price transaction with no set-aside designation. The contractor will perform this delivery order from its corporate office location in Conshohocken, Pennsylvania. This award falls under...
- The Defense Logistics Agency awarded a delivery order valued at $11,163.12 to AmerisourceBergen Drug Corp for the supply of Prilosec DR 10 mg Suspension in 30-count packaging. This firm fixed-price contract, awarded on August 5, 2025, with an ultimate completion date of August 6, 2025, represents a non-set-aside competitive award. The work will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is executed under the company's larger...
- The Defense Logistics Agency awarded a delivery order valued at $1,963.98 to AmerisourceBergen Drug Corp for the supply of Prilosec DR 10 mg suspension (30 count) on December 17, 2025, with an ultimate completion date of December 18, 2025. This is a firm fixed price delivery order with no set-aside designation, utilizing a competitive award process. The product will be delivered to AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under...
- SPE2DB20D3101Indefinite Delivery Contract
- SPE2DB20D3101-SPE2DB23FRRY7Delivery Order
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $23,833.82 firm-fixed-price delivery order is for the supply of Prilosec DR 10 mg suspension in 30-count packages. The contract has an ultimate completion date of July 18, 2023. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. This delivery order is likely part of that broader IDC. The contract does not have a set-aside designation, indicating open competition. As a critical vendor for federal healthcare programs, particularly within military and veterans' healthcare systems, AmerisourceBergen has demonstrated a broad spectrum of pharmaceutical and medical supply procurement across multiple federal agencies.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $23.8k | 7/17/23 |